Keywords
RepurposingCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineOutbreakDrug repositioningClinical trialCoronavirusCoronavirus InfectionsBetacoronavirusVirologyPneumoniaIntensive care medicinePharmacologyBiologyInfectious disease (medical specialty)Internal medicineDiseaseDrug
MeSH Terms
Adenosine MonophosphateAlanineAntiviral AgentsBetacoronavirusCOVID-19Coronavirus InfectionsDrug RepositioningHIV InfectionsHepatitis BHepatitis CHumansInfluenzaHumanInterferon-alphaMiddle East Respiratory Syndrome CoronavirusNucleosidesPneumoniaViralPolyethylene GlycolsProtease InhibitorsRecombinant ProteinsSevere acute respiratory syndrome-related coronavirusSARS-CoV-2Spike GlycoproteinCoronavirusCOVID-19 Drug Treatment
Affiliated Institutions
Related Publications
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epi...
Return of the Coronavirus: 2019-nCoV
The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained f...
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia
Abstract Background A novel coronavirus of zoonotic origin (2019-nCoV) has recently been identified in patients with acute respiratory disease. This virus is genetically similar...
A Novel Coronavirus from Patients with Pneumonia in China, 2019
In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discov...
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies
In December of 2019, an outbreak of pneumonia caused by an unknown aetiology occurred in Wuhan, China and most patients were linked to a single seafood market, which reportedly ...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 19
- Issue
- 3
- Pages
- 149-150
- Citations
- 1808
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1808
OpenAlex
75
Influential
1311
CrossRef
Cite This
Guangdi Li,
Erik De Clercq
(2020).
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Nature Reviews Drug Discovery
, 19
(3)
, 149-150.
https://doi.org/10.1038/d41573-020-00016-0
Identifiers
- DOI
- 10.1038/d41573-020-00016-0
- PMID
- 32127666